Senate subcommittee examines new pricing policies for contact lenses

The Senate Subcommittee on Antitrust Competition Policy and Consumer Rights held a hearing July 30 to explore contact lens pricing strategies initiated recently by contact lens manufacturers that would affect retail price competition, Sen. Amy Klobuchar (D-Minn.) said as she presided over the proceedings.“This is intended as an exploratory hearing to give the subcommittee and regulators a better understanding of the reasons for the minimum pricing arrangements in this particular market,” Sen. Michael S. Lee (R-Utah) said at the hearing. “Price matters in this market. I’ve heard that as prices (Read more...)

Allergan files lawsuit against Valeant, Pershing Square for federal securities violations

Allergan has filed a lawsuit in the U.S. District Court against Valeant Pharmaceuticals, Pershing Square Capital Management, and its principal, William A. Ackman, citing violations to federal securities laws prohibiting insider trading, engagement in fraudulent practices and failure to disclose legally required information.The complaint alleges that between February and April 2014, Pershing Square purchased Allergan stock and securities valued at more than $3.2 billion from unknowing Allergan stockholders, with full understanding of Valeant’s non-public takeover intensions.

BLOG: Managing associate optometrists in your practice, part 4

As with eye surgeons, not all optometrists are created equally. It’s a broad but true generalization that younger ODs are better trained and equipped to step into a busy ophthalmic practice. Sparky doctors, both in intelligence and energy, can see more patients than dull docs.Recruiting a high-quality optometrist is generally much easier than finding a top-flight ophthalmologist. It pays to aim for a higher-quality doctor; small increments in compensation can yield large benefits in productivity and ease of management. Here’s a sample ad with all the right buzz words